At a glance
- Originator Nonindustrial source
- Class Antibacterials; Antifungals; Antivirals; Macrolides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Herpes simplex virus infections
Most Recent Events
- 16 Feb 2001 Profile reviewed but no significant changes made
- 09 Sep 1998 No-Development-Reported for Herpes simplex virus infections in Japan (Unknown route)
- 18 Apr 1996 New profile